Delphine Guillemot

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Expanding the Spectrum of Ubiquitin-specific Proteases-Fused Neoplasms: A Clinicopathologic and Molecular Study of USP2- and USP8-Rearranged Spindle Cell Tumors.

Expanding the Spectrum of Ubiquitin-specific Proteases-Fused Neoplasms: A Clinicopathologic and Molecular Study of USP2- and USP8-Rearranged Spindle Cell Tumors.

Journal: The American journal of surgical pathology

Published: February 15, 2026

The malignant transformation of an atypical angiocentric glioma, MYB-altered.

The malignant transformation of an atypical angiocentric glioma, MYB-altered.

Journal: Acta neuropathologica communications

Published: March 05, 2025

Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions.

Expanding the clinicopathologic spectrum and genomic landscape of tumors with SMARCA2/4::CREM fusions.

Journal: The Journal of pathology

Published: June 10, 2024

CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series.

CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic series.

Journal: Brain pathology (Zurich, Switzerland)

Published: April 08, 2024

Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology.

Diffuse glioneuronal tumor with oligodendroglioma-like features and nuclear clusters (DGONC), new name and new problems: an illustration of one case with atypical morphology and biology.

Journal: Acta neuropathologica communications

Published: April 08, 2024

FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.

FGFR1 fusions as a novel molecular driver in rhabdomyosarcoma.

Journal: Genes, chromosomes & cancer

Published: January 29, 2024

CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.

CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.

Journal: Acta neuropathologica communications

Published: October 12, 2023

Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis.

Neurotrophic tropomyosin receptor kinase (NTRK) fusion positive tumors: a historical cohort analysis.

Journal: Expert review of anticancer therapy

Published: July 12, 2023

Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.

Imaging characterization of paediatric tumours with the neurotrophic tyrosine receptor kinase fusion transcript.

Journal: The British journal of radiology

Published: June 28, 2023

Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse.

Sequential genomic analysis using a multisample/multiplatform approach to better define rhabdomyosarcoma progression and relapse.

Journal: NPJ precision oncology

Published: March 07, 2023

CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm.

CNS neuroblastoma, FOXR2-activated and its mimics: a relevant panel approach for work-up and accurate diagnosis of this rare neoplasm.

Journal: Acta neuropathologica communications

Published: January 27, 2023

CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.

CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.

Journal: Acta neuropathologica communications

Published: December 09, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026